Faes Farma Stock

Faes Farma EBIT

The EBIT of Faes Farma (FAE.MC) as of Aug 5, 2026 is 76.26 M EUR. In the previous year, EBIT was 107.08 M EUR — a change of -28.78% (lower).

EBIT

76.26 MEUR

YoY

-28.78%

Last updated:

In 2026, Faes Farma's EBIT was 76.26 M EUR, a -28.78% increase from the 107.08 M EUR EBIT recorded in the previous year.

The Faes Farma EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M EUR)
Date
EBIT (M EUR)
Jan 1, 2023
81.22 base
Jan 1, 2024
107.08 base
Jan 1, 2025
76.26 base
Jan 1, 2026 (e)
157.00 base
Jan 1, 2027 (e)
164.14 base
Jan 1, 2028 (e)
176.80 base
Jan 1, 2029 (e)
190.66 base
Jan 1, 2030 (e)
206.32 base
YEAREBIT (M EUR)
2030 est 206.32
2029 est 190.66
2028 est 176.80
2027 est 164.14
2026 est 157.00
2025 76.26
2024 107.08
2023 81.22
2022 79.35
2021 93.58
2020 85.43
2019 78.81
2018 62.01
2017 50.95
2016 47.98
2015 41.84
2014 36.18
2013 28.67
2012 22.86
2011 14.85
2010 23.28
2009 14.10
2008 26.96
2007 21.19
2006 22.65
Access this data via the Eulerpool API

Faes Farma Revenue

Faes Farma Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
451.17 M EUR
81.22 M EUR
91.90 M EUR
Jan 1, 2024
493.65 M EUR
107.08 M EUR
111.36 M EUR
Jan 1, 2025
610.46 M EUR
76.26 M EUR
79.63 M EUR
Jan 1, 2026 (e)
758.51 M EUR
157.00 M EUR
99.42 M EUR
Jan 1, 2027 (e)
793.00 M EUR
164.14 M EUR
110.14 M EUR
Jan 1, 2028 (e)
854.16 M EUR
176.80 M EUR
124.98 M EUR
Jan 1, 2029 (e)
921.13 M EUR
190.66 M EUR
145.29 M EUR
Jan 1, 2030 (e)
996.80 M EUR
206.32 M EUR
165.60 M EUR

Faes Farma Margins

Faes Farma stock margins

The Faes Farma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Faes Farma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Faes Farma.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
65.86 %
18.00 %
20.37 %
Jan 1, 2024
66.15 %
21.69 %
22.56 %
Jan 1, 2025
37.42 %
12.49 %
13.04 %
Jan 1, 2026 (e)
37.42 %
20.70 %
13.11 %
Jan 1, 2027 (e)
37.42 %
20.70 %
13.89 %
Jan 1, 2028 (e)
37.42 %
20.70 %
14.63 %
Jan 1, 2029 (e)
37.42 %
20.70 %
15.77 %
Jan 1, 2030 (e)
37.42 %
20.70 %
16.61 %

Faes Farma Stock analysis

What does Faes Farma do? The history of Faes Farma SA dates back to 1933, when the company was founded in Barcelona, Spain. The founders had a vision to develop innovative products that would contribute to improving the health and well-being of people. Over the following decades, the company grew continuously and established itself as one of the leading players in the pharmaceutical industry. The business model of Faes Farma SA is focused on the development and marketing of products for the healthcare industry. The company relies on research and development to develop innovative solutions for various therapeutic areas. Faes Farma SA distributes its products worldwide through a network of partners and distributors, with a focus on Europe and Latin America. Faes Farma SA operates in three different divisions. The first division is pharmaceuticals, where the company offers products for various areas such as respiratory diseases, allergies, pain, and inflammation. An important part of this segment is the product Bilastine, which is used for the treatment of allergies and is considered an alternative to antihistamines. The second division is animal health. Here, Faes Farma SA offers products for the treatment of pets, including preparations against fleas, ticks, and worms. One of the most well-known products in this area is the Stangest brand, which is considered the leading brand for animal health in Spain. The third division of Faes Farma SA is the business of medical devices and diagnostics. Here, the company offers a wide range of products for various medical applications, including devices for monitoring vital signs and diagnostics for infectious diseases. Overall, Faes Farma SA is a company with a diversified product portfolio that is of interest to both end consumers and healthcare professionals and pet owners. The company has continuously developed and invested in research and development in recent years to expand its product offering and provide innovative solutions for various medical needs. Faes Farma SA is a company that stands out for its commitment to the development of innovative products and its dedication to the health and well-being of humans and animals. With a strong focus on research and development and a wide distribution network, the company has solidified its position in the pharmaceutical industry and will continue to play an important role in the market. Faes Farma is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Faes Farma's EBIT

Faes Farma's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Faes Farma's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Faes Farma's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Faes Farma’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Faes Farma stock

EBIT of Faes Farma is 76.26 M EUR in 2026.

EBIT of Faes Farma changed from 107.08 M EUR to 76.26 M EUR, representing a -28.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Faes Farma since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Faes Farma historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Faes Farma

All Key Metrics — Faes Farma